Dr. Paul Sufka: Blockchain Management
Dr. Paul Sufka discusses blockchain management at the ACR/ARHP Annual Meeting in Chicago.
Dr. Naomi Schlesinger with Dr. Mohammed Tikly
Dr. Naomi Schlesinger interviews Dr. Mohammed Tikly from South Africa at the ACR/ARHP Annual Meeting in Chicago.
Dr. John Cush RheumNow
7 years 11 months ago
Here are online abstracts from the Sept 2018 Brazilian Congress of Rheumatology meeting. https://t.co/icB0emM1dN
The monoclonal antibody bimekizumab, which neutralizes both interleukin (IL)-17A and 17F, was effective for both musculoskeletal and skin outcomes in psoriatic arthritis (PsA) in a phase IIb study.
Dr. John Cush RheumNow
7 years 11 months ago
CBC: neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR) are significantly elevated in #RA and is as effective as CRP & ESR in correlating w/ DAS28-ESR https://t.co/K15vSHywfI https://t.co/xvqMWMqU0t
Dr. John Cush RheumNow
7 years 11 months ago
Nationwide Inpatient Database (2005-2014) studied 2036 SLE patients with MI (STEMI and NonSTEMI) and showed hospital outcomes (Mortality, CABG, AE, hosp stay, costs) same as non-SLE patients. https://t.co/VpOrNh1fq0
ACR 2018 has come and gone. It was a conference filled with a number of highlights. One thing from this conference which really stood out was the continued plethora of data on JAK inhibitors. First in RA, and now in psoriatic arthritis and psoriasis.
Dr. John Cush RheumNow
7 years 11 months ago
In contrast to RF, ACPA is not increased in HCV infection; among 271 HCV‐infected pts (no arthritis) they found 47% RF+, 1.1% ACPA+, 8.9% high‐positive RF, and 1.1% high‐positive ACPA. https://t.co/35wFgGVWcH
Drs. Arthur Kavanaugh, Doug White and Angus Worthing: Biosimilars
Drs. Arthur Kavanaugh, Doug White and Angus Worthing discuss biosimilars at the ACR/ARHP Annual Meeting in Chicago.
Panel Discussion: Tips for Fellows
Drs. Rachel Tate, Paul Sufka, Kathryn Dao and Julie Jones offer tips for rheumatology fellows in this panel discussion at the ACR/ARHP Annual Meeting in Chicago.
Dr. Olga Petryna: Osteoporotic Refractures in Autoimmune Patients
Dr. Olga Petryna discusses poster 1182 as presented at the ACR/ARHP Annual Meeting in Chicago.
Here are a few important advances in our understanding of interstitial lung disease (ILD) from the ACR 2018 meeting last week.
Two studies presented at ACR18 have used imaging to examine one of the key unanswered questions in polymyalgia rheumatica - what structures are the focus of inflammation in the disease – and demonstrated that peritendineal involvement is ubiquitous in and distinctive of PMR.
Dr. John Cush RheumNow
7 years 11 months ago
Taiwan claims data shows that among 4036 psoriasis pts with HTN followed for 5.4 yrs, there was a 28% higher risk of cardiovascular procedures and surgery (aHR 1.28; 95% CI, 1.07-1.53); moreso in PsA and with severe psoriasis. https://t.co/cgpY8s3WDs
